Iterum Therapeutics Plc (ITRM)
0.421
-0.03
(-6.44%)
USD |
NASDAQ |
Dec 15, 16:00
0.4239
0.00 (0.00%)
After-Hours: 20:00
Iterum Therapeutics Free Cash Flow: -19.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alkermes Plc | 490.87M |
| Amarin Corp. Plc | -21.82M |
| Jazz Pharmaceuticals Plc | 1.282B |
| Prothena Corp. Plc | -191.52M |
| GH Research Plc | -42.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.848M |
| Cash from Investing (Quarterly) | -0.0126M |
| Cash from Financing (Quarterly) | 5.658M |
| Free Cash Flow Per Share (Quarterly) | -0.1716 |
| Free Cash Flow to Equity (Quarterly) | -9.037M |
| Free Cash Flow to Firm (Quarterly) | -7.290M |
| Free Cash Flow Yield | -127.3% |